Gallbladder cancer rates were found to be low and similar among both patients with and without gallbladder polyps, according to a recent study.
Families of dying adolescents were found to have a poor understanding of their adolescent’s values in terms of their own end-of-life care.
The FDA granted fast track designation for CLR 131 in lymphoplasmacytic lymphoma/Waldenstrom’s macroglobulinemia in patients having received 2 prior treatment regimens or more.
Clinically important increases in melanoma risk in patients treated with biologic therapy for common inflammatory diseases cannot yet be ruled out based on current evidence.
Researchers found that patients with metastatic pancreatic cancer who had germline or somatic mutations in DNA repair genes had better clinical outcomes after platinum-based chemotherapy.
Patients with pretreated microsatellite instability-high cancers treated with immune checkpoint inhibitors were found to have high activity, independent of tumor type and drug used.
This study suggested that Medicaid expansion could have survival benefits for men with non-small cell lung cancer, however the same association pattern was not observed for women.
A phase II study indicated that low-dose erlotinib (Tarceva) appears to be safe and effective in elderly or frail patients with EGFR mutation-positive non-small cell lung cancer.
A workshop group assessed the use of multidimensional data obtained from patients with cancer and the computational methods used to analyze the data.
Recommendations for patients who develop COVID-19 while receiving immunotherapy or other advanced immune-engaging therapies.